Cardiac magnetic resonance imaging for evaluating subclinical cardiotoxicity following chemotherapy in postoperative breast cancer patients

Key Points

• This study aims to investigate subclinical cardiotoxicity in patients undergoing chemotherapy after breast cancer surgery using cardiac magnetic resonance imaging.
• Conducted as a randomized trial involving postoperative breast cancer patients receiving chemotherapy.
• Utilized cardiac magnetic resonance imaging for assessment of cardiac health following treatment.
• Detected subclinical cardiotoxicity in a significant number of patients via imaging techniques.
• Demonstrated that cardiac magnetic resonance imaging can effectively identify early signs of heart damage post-chemotherapy.